6-[2-(2-chloro-5-methoxy-phenoxy)ethoxy]-5-(5-methylsulfanylpyrimidin-2-yl)-N-(propylsulfamoyl)pyrimidin-4-amine

ID: ALA4528516

PubChem CID: 155544917

Max Phase: Preclinical

Molecular Formula: C21H25ClN6O5S2

Molecular Weight: 541.06

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCNS(=O)(=O)Nc1ncnc(OCCOc2cc(OC)ccc2Cl)c1-c1ncc(SC)cn1

Standard InChI:  InChI=1S/C21H25ClN6O5S2/c1-4-7-27-35(29,30)28-20-18(19-23-11-15(34-3)12-24-19)21(26-13-25-20)33-9-8-32-17-10-14(31-2)5-6-16(17)22/h5-6,10-13,27H,4,7-9H2,1-3H3,(H,25,26,28)

Standard InChI Key:  TYLZGSIGPRVNQJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 37  0  0  0  0  0  0  0  0999 V2000
   11.4778  -12.8150    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8905  -13.5249    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.2990  -12.8126    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.8974  -15.1593    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8962  -15.9788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6043  -16.3878    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3139  -15.9783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3111  -15.1557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6025  -14.7504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6001  -13.9332    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1846  -13.9374    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0223  -16.3858    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0236  -17.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7319  -17.6105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7332  -18.4277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4416  -18.8352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4385  -19.6508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1460  -20.0582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8540  -19.6485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8501  -18.8270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1420  -18.4233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4748  -13.5326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7692  -13.9449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0594  -13.5400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0142  -14.7457    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7238  -15.1533    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4295  -14.7428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4268  -13.9247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7126  -13.5190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0099  -13.9319    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1324  -13.5125    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.8422  -13.9175    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5557  -18.4148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2655  -18.8198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7302  -20.0585    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
 10  2  1  0
  2 11  1  0
  7 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 11 22  1  0
 22 23  1  0
 23 24  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
  8 25  1  0
 28 31  1  0
 31 32  1  0
 20 33  1  0
 33 34  1  0
 17 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4528516

    ---

Associated Targets(Human)

EDNRA Tclin Endothelin receptor ET-A (5008 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EDNRB Tclin Endothelin receptor ET-B (1928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 541.06Molecular Weight (Monoisotopic): 540.1016AlogP: 3.43#Rotatable Bonds: 13
Polar Surface Area: 137.45Molecular Species: NEUTRALHBA: 10HBD: 2
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.34CX Basic pKa: 2.56CX LogP: 3.19CX LogD: 2.90
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.24Np Likeness Score: -1.36

References

1. Boss C, Bolli MH, Gatfield J..  (2016)  From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective.,  26  (15): [PMID:27321813] [10.1016/j.bmcl.2016.06.014]

Source